Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
6-APB
MDEA
Bufotenin
5-MeO-DiPT
Phenylpiracetam
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:300µg AL-LAD - Don't worry, because you're everyone!
5-MeO-DALT
TMA-6
TMA-2
4-HO-DPT
DiPT
25B-NBOH
2C-B
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
DOB
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
EPT
MDA
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
MDAI
DET
2C-B-FLY
2C-I
4-HO-MPT
Mescaline
2C-P
Bromo-DragonFLY
AL-LAD
Omberacetam
Memantine
Psilocybin mushrooms
ETH-LAD
JWH-018
2C-T-7
3C-E
Allylescaline
LSD
25N-NBOMe
Proscaline
Experience:120mg - Garden of The Gods
Escaline
Oxiracetam
PARGY-LAD
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
2C-C
4-FA
Pramiracetam
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
2C-D
GABAergic hallucinogens
THJ-2201
4-AcO-DET
Selective serotonin reuptake inhibitor
Amanita muscaria
5-MeO-MiPT
MET
JWH-073
25D-NBOMe
MiPLA
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:800 seeds LSA - My First Trip Ever
ΑMT
5-Hydroxytryptophan
MiPT
4-HO-DiPT
LSZ
Experience:3-MeO-PCP - Extreme psychosis
Experience:BK-2C-B - Various experiences
PRO-LAD
4-HO-MET
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:25mg 3-MeO-PCP - Enhanced film experience
1P-ETH-LAD
25B-NBOMe
Ibogaine
Experience:1000 Morning Glory seeds - Rediscovering the Self
Chameleon.jpgChameleon by Anonymous.
2C-T-2
25C-NBOMe
ALD-52
1B-LSD
LSA
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:4-HO-MiPT / A care free psychedelic getaway
4-HO-EPT
5-MeO-DiBF
5F-PB-22
DOC
4-AcO-MET
25I-NBOH
Ayahuasca
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:25mg Deschloroketamine - My first time orally dosing DCK
DMT
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Tree.jpgJapanese Garden by Anonymous
Piracetam
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
MPT
Pregabalin
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
2C-E
Experience:40mg - Brothermind and the Forest's Hand
LSM-775
1P-LSD
Βk-2C-B
2C-T-21
4-HO-MiPT
THJ-018
Psilocin
DPT
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
25C-NBOH
Enhancement of colour rose.jpgRose by Chelsea Morgan
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:4x 200ug tabs - You do not need to understand
Methallylescaline
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
25I-NBOMe
4-HO-DET
2C-H
Aniracetam
Phenethylamine (compound)
4-AcO-DiPT
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:2 tabs DOB - My DOB Nightmare
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
4-AcO-MiPT
DOI
4-AcO-DMT
Efavirenz
Experience:250mg DXM - DXM Itch and Trip Report
6-APDB
Cannabis
MDMA
3-MMC
Experience:337mg DMT fumarate - A Day With DMT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
3-MeO-PCE

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.